18
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Vitamin D Nutrition and its Potential Health Benefits for Bone, Cancer and Other Conditions

Pages 275-291 | Published online: 13 Jul 2009

  • Harris LJ. Vitamin D and rickets. In: Anonymous. Vitamins in Theory and Practice. Cambridge: Cambridge University Press, 1935, 107-50.
  • Blumberg RW, Forbes GB, Fraser D et al. The prophylactic requirement and the toxicity of vitamin D. Pediatrics 1963; 31: 512-25.
  • Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes: Calcium, Phosphorus , Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press, 1997.
  • Marx SJ, Jones G, Weinstein RS, Chrousos GP, Renquist DM. Differences in mineral metabolism among nonhuman primates receiving diets with only vitamin D3 or only vitamin D2. J Clin Endocrinol Metab 1989; 69: 1282-9.
  • Trang H, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitami n D more efficiently than does vitamin D2. Am J Clin Nutr 1998; 68: 854-8.
  • Park EA. The therapy of rickets. JAMA 1940; 115: 370-9.
  • Bicknell F, Prescott F. Vitamin D. The antirachiti c or calcifying vitamin. In: Bicknell F, Prescott F (eds) Vitamins in Medicine. London: Whitefriars Press, 1946, 630-707.
  • Chapuy MC, Preziosi P, Maamer M et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis Int 1997; 7: 439-43.
  • Souberbielle JC, Cormier C, Kindermans C et al. Vitamin D status and rede. ning serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 2001; 86: 3086-90.
  • Lips P, Duong T, Oleksik A et al. A global study of vitamin D status and parathyroi d function in postmenopausal women with osteoporosis : baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001; 86: 1212-21.
  • Lips P. Vitamin D deficiency and secondary hyperparathyroidis m in the elderly: consequence s for bone loss and fractures and therapeuti c implications. Endocr Rev 2001; 22: 477-501.
  • Vieth R. Problems with direct 25-hydroxyvitami n D assays and the target amount of vitamin D nutrition desirable for patients with osteoporosis. Osteoporosis Int 2000; 11: 635-6.
  • Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D(3) intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001; 73: 288-94.
  • Heaney RP, Barger-Lux MJ, Dowell MS, Chen TC, Holick MF. Calcium absorptive effects of vitamin D and its major metabolites [In Process Citation]. J Clin Endocrinol Metab 1997; 82: 4111-16.
  • Norman AW, Ishizuka S, Okamura WH. Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonist s for genomic and rapid response receptor s or as a ligand for the plasma vitamin D binding protein. J Steroid Biochem Mol Biol 2001; 76: 49-59.
  • Vieth R, Cole DE, Hawker G, Trang H, Rubin LA. Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr (in press).
  • Serenius F, Elidrissy AT, Dandona P. Vitamin D nutrition in pregnant women at term and in newly born babies in Saudi Arabia. J Clin Pathol 1984; 37: 444-7.
  • Lehtonen-Veromaa M, Mottonen T, Irjala K et al. Vitamin D intake is low and hypovitaminosis D common in healthy 9- to 15-year old Finnish girls. Eur J Clin Nutr 1999; 53: 746-51.
  • Glerup H, Mikkelsen K, Poulsen L et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 2000; 247: 260-8.
  • Glerup H, Mikkelsen K, Poulsen L et al. Hypovitaminosis D myopathy without biochemical signs of osteomalaci c bone involvement. Calcif Tissue Int 2000; 66: 419-24.
  • Heaney RP. Vitamin D: how much do we need, and how much is too much? Osteoporosis Int (in press).
  • Moon J, Bandy B, Davison AJ. Hypothesis: etiology of atherosclerosis and osteoporosis : are imbalances in the calciferol endocrine system implicated? J Am Coll Nutr 1992; 11: 567-83.
  • Koutkia P, Chen TC, Holick MF. Vitamin D intoxication associated with an over-the-counter supplement. N Engl J Med 2001; 345: 66-7.
  • Yates AA. Process and development of dietary reference intakes: basis, need, and application of recommended dietary allowances. Nutr Rev 1998; 56: S5-9.
  • Kinyamu HK, Gallagher JC, Rafferty KA, Balhorn KE. Dietary calcium and vitamin D intake in elderly women: effect on serum parathyroi d hormone and vitamin D metabolites. Am J Clin Nutr 1998; 67: 342-8.
  • Meunier P. Vitamin D insufficiency: reappraisal of its de. nition threshold and bone consequences. In: Burckhardt P, Dawson-Hughes B, Heaney R (eds) Nutritional Aspects of Osteoporosis. San Diego: Academic Press, 2001, 152-72.
  • Dawson-Hughes B, Dallal GE, Krall EA, Harris S, Sokoll LJ, Falconer G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women [see comments]. Ann Intern Med 1991; 115: 505-12.
  • Chapuy MC, Arlot ME, Duboeuf F et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327: 1637-42.
  • Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older [see comments]. N Engl J Med 1997; 337: 670-6.
  • Harris SS, Soteriades E, Dawson-Hughes B. Secondary hyperparathyroidis m and bone turnover in elderly blacks and whites. J Clin Endocrinol Metab 2001; 86: 3801-4.
  • Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidis m in elderly women [In Process Citation]. J Bone Miner Res 2000; 15: 1113-18.
  • Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 1993; 91: 2552-5.
  • Bouillon RA, Auwerx JH, Lissens WD, Pelemans WK. Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalcifero l deficiency. Am J Clin Nutr 1987; 45: 755-63.
  • Himmelstein S, Clemens TL, Rubin A, Lindsay R. Vitamin D supplementation in elderly nursing home residents increases 25(OH)D but not 1,25(OH)2D. Am J Clin Nutr 1990; 52: 701-6.
  • Landin-Wilhelmse n K, Wilhelmsen L, Wilske J et al. Sunlight increases serum 25(OH) vitamin D concentratio n whereas 1,25(OH)2D3 is unaffected. Results from a general population study in Goteborg, Sweden (The WHO MONICA Project). Eur J Clin Nutr 1995; 49: 400-7.
  • Need AG, Horowitz M, Morris HA, Nordin BC. Vitamin D status: effects on parathyroi d hormone and 1,25-dihydroxyvitami n D in postmenopausal women. Am J Clin Nutr 2000; 71: 1577-81.
  • Ishimura E, Nishizawa Y, Inaba M et al. Serum levels of 1,25-dihydroxyvitami n D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitami n D in nondialyzed patients with chronic renal failure. Kidney Int 1999; 55: 1019-27.
  • Zehnder D, Bland R, Williams MC et al. Extrarenal expression of 25-hydroxyvitami n D(3)-1alphahydroxylase. J Clin Endocrinol Metab 2001; 86: 888-94.
  • Zineb R, Zhor B, Odile W, Marthe RR. Distinct, tissue-speci fic regulation of vitamin D receptor in the intestine, kidney, and skin by dietary calcium and vitamin D [In Process Citation]. Endocrinology 1998; 139: 1844-52.
  • Vieth R. The mechanisms of vitamin D toxicity. Bone Miner 1990; 11: 267-72.
  • Vieth R, Chan A, Pollard A. 125I-RIA kit cannot distinguish vitamin D deficiency as well as a more specific assay for 25-hydroxyvitami n D. Clin Biochem 1995; 28: 175-9.
  • Reddy GS, Tsering KY, Thomas BR, Dayal R, Norman AW. Isolation and identification of 1,23-dihydroxy-24,25,26,27-tetran orvitamin D3, a new metabolite of 1,25-dihydroxyvitami n D3 produced in rat kidney. Biochemistry 1987; 26: 324-31.
  • Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1997; 30: 150-6.
  • Krause R, Buhring M, Hopfenmuller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure [Letter]. Lancet 1998; 352: 709-10.
  • Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologi a 2000; 43: 1093- 8.
  • Vitamin D supplement in early childhood and risk for Type I (insulin-dependent ) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia 1999; 42: 51-4.
  • McAlindon TE, Felson DT, Zhang Y et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann Intern Med 1996; 125: 353- 9.
  • Lane NE, Gore LR, Cummings SR et al. Serum vitamin D levels and incident changes of radiographic hiposteoarthritis : a longitudinal study. Study of Osteoporotic Fractures Research Group. Arthritis Rheum 1999; 42: 854-60.
  • Fuller K. Low birth-weight infants: the continuing ethnic disparity and the interaction of biology and environment. Ethnic Dis 2000; 10: 432-45.
  • Muhe L, Lulseged S, Mason KE, Simoes EA. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet 1997; 349: 1801-4.
  • Hayes CE, Cantorna MT, DeLuca HF. Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med 1997; 216: 21-7.
  • Mahon BD, Bemiss C, Cantorna MT. Altered cytokine pro. le in patients with multiple sclerosis following vitamin D supplementation. FASEB J 2001; 837: 4.
  • Embry AF, Snowdon LR, Vieth R. Vitamin D and seasonal fl uctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000; 48: 271-2.
  • Chan TY. Vitamin D deficiency and susceptibilit y to tuberculosis. Calcif Tissue Int 2000; 66: 476-8.
  • Douglas AS, Ali S, Bakhshi SS. Does vitamin D deficiency account for ethnic difference s in tuberculosis seasonality in the UK? Ethn Health 1998; 3: 247-53.
  • Grant WB. An estimate of excess cancer mortality in the US due to inadequat e exposure to solar UV-B radiation (abstract). Photodermatol Photoimmunol Photomed 2001; 17: 142.
  • Garland CF, Garland FC, Gorham ED. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann NY Acad Sci 1999; 889: 107-19.
  • Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP. 1 alpha,25-dihydroxyvitami n D (calcitriol) inhibits the invasivenes s of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev 1997; 6: 727-32.
  • Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF. Human prostate cells synthesize 1,25-dihydroxyvitami n D3 from 25-hydroxyvitami n D3 [In Process Citation]. Cancer Epidemiol Biomarkers Prev 1998; 7: 391-5.
  • Hsu JY, Feldman D, McNeal JE, Peehl DM. Reduced 1alpha-hydroxylas e activity in human prostate cancer cells correlates with decreased susceptibilit y to 25-hydroxyvitami n D3-induced growth inhibition. Cancer Res 2001; 61: 2852-6.
  • Lefkowitz ES, Garland CF. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol 1994; 23: 1133- 6.
  • Martinez ME, Giovannucc i EL, Colditz GA et al. Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst 1996; 88: 1375-82.
  • Tangrea J, Helzlsouer K, Pietinen P et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 1997; 8: 615-25.
  • Garland CF, Garland FC, Gorham ED. Can colon cancer incidence and death rates be reduced with calcium and vitamin D? Am J Clin Nutr 1991; 54: 193S-201S.
  • Emerson JC, Weiss NS. Colorectal cancer and solar radiation. Cancer Causes Control 1992; 3: 95-9.
  • Schwartz GG. Multiple sclerosis and prostate cancer: what do their similar geographie s suggest? Neuroepidemiolog y 1992; 11: 244-54.
  • Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992; 70: 2861-9.
  • Ainsleigh HG. Beneficial effects of sun exposure on cancer mortality [Review]. Prevent Med 1993; 22: 132-40.
  • Hayes CE. Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc 2000; 59: 531-5.
  • McGrath J. Does 'imprinting' with low prenatal vitamin D contribute to the risk of various adult disorders ? Med Hypotheses 2001; 56: 367-71.
  • Pfeifer M, Bergerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementatio n on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2001; 16(6): 1115-18.
  • McMurray DN, Bartow RA, Mintzer CL, Hernandez-Fronter a E. Micronutrient status and immune function in tuberculosis. Ann NY Acad Sci 1990; 587: 59-69.
  • Goodwin JS, Tangum MR. Battling quackery: attitudes about micronutrient supplements in American academic medicine. Arch Intern Med 1998; 158: 2187-91.
  • Lau KW, Baylink DJ. Vitamin D therapy of osteoporosis : plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. Calcif Tissue Int 1999; 65: 295-306.
  • Adachi JD, Bensen WG, Bianchi F et al. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis : a 3 year followup [see comments]. J Rheumatol 1996; 23: 995-1000.
  • Adachi JD, Ioannidis G. Calcium and vitamin D therapy in corticosteroid-induce d bone loss: what is the evidence? [In Process Citation]. Calcif Tissue Int 1999; 65: 332- 6.
  • Webb AR, DeCosta BR, Holick MF. Sunlight regulate s the cutaneous production of vitamin D3 by causing its photodegradation. J Clin Endocrinol Metab 1989; 68: 882-7.
  • Holick MF, MacLaughlin JA, Doppelt SH. Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. Science 1981; 211: 590- 3.
  • Stamp TC. Factors in human vitamin D nutrition and in the production and cure of classical rickets. Proc Nutr Soc 1975; 34: 119-30.
  • Davie MW, Lawson DE, Emberson C, Barnes JL, Roberts GE, Barnes ND. Vitamin D from skin: contribution to vitamin D status compared with oral vitamin D in normal and anticonvulsant-treated subjects. Clin Sci 1982; 63: 461-72.
  • Chel VG, Ooms ME, Popp-Snijders C et al. Ultraviolet irradiation corrects vitamin D deficiency and suppresse s secondary hyperparathyroidis m in the elderly [In Process Citation]. J Bone Miner Res 1998; 13: 1238-42.
  • Holick MF. Environmental factors that infl uence the cutaneous production of vitamin D. Am J Clin Nutr 1995; 61: 638S-45S.
  • Haddock L, Corcino J, Vazquez Md. 25(OH)D serum levels in the normal Puerto Rican population and in subjects with tropical sprue and parathyroi d disease. Puerto Rico Health Sci J 1982; 1: 85-91.
  • Haddad JG, Kyung JC. Competitive protein-bindin g radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol 1971; 33: 992-5.
  • Better OS, Shabtai M, Kedar S, Melamud A, Berenheim J, Chaimovitz C. Increased incidence of nephrolithiasis in lifeguards in Israel. In: Massry SG, Ritz E, Jahreis G (eds) Phosphate and Minerals in Health and Disease. New York: Plenum Press, 1980, 467-72.
  • Matsuoka LY, Wortsman J, Hollis BW. Suntanning and cutaneous synthesis of vitamin D3. J Lab Clin Med 1990; 116: 87-90.
  • Mawer EB, Berry JL, Sommer-Tsilenis E, Beykirch W, Kuhlwein A, Rohde BT. Ultraviolet irradiation increases serum 1,25-dihydroxyvitami n D in vitamin-D-replet e adults. Miner Electrolyte Metab 1984; 10: 117-21.
  • Stamp TC, Haddad JG, Twigg CA. Comparison of oral 25-hydroxycholecalciferol , vitamin D, and ultraviole t light as determinant s of circulating 25-hydroxyvitami n D. Lancet 1977; 1: 1341-3.
  • Dent CE, Round JM, Rowe DJ, Stamp TC. Effect of chapattis and ultraviolet irradiation on nutritional rickets in an Indian immigrant. Lancet 1973; 1: 1282- 4.
  • Varghese M, Rodman JS, Williams JJ et al. The effect of ultraviolet B radiation treatments on calcium excretion and vitamin D metabolites in kidney stone formers. Clin Nephrol 1989; 31: 225-31.
  • Falkenbach A, Unkelbach U, Boehm BO et al. Bone metabolism before and after irradiation with ultraviolet light. Eur J Appl Physiol 1993; 66: 55-9.
  • Vieth R. Vitamin D supplementation , 25-hydroxyvitami n D concentrations , and safety. Am J Clin Nutr 1999; 69: 842-56.
  • Anonymous. Recommended Dietary Allowances, 7th edn. Washington, DC: National Academy Press, 1968.
  • Ooms ME, Roos JC, Bezemer PD, Van Der Vijgh WJF, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementatio n in elderly women: a randomized double-blin d trial. J Clin Endocrinol Metab 1995; 80: 1052-8.
  • Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementatio n and fracture incidence in elderly persons. A randomized, placebo-controlle d clinical trial. Ann Intern Med 1996; 124: 400-6.
  • McAuley KA, Jones S, Lewis-Barned NJ, Manning P, Goulding A. Low vitamin D status is common among elderly Dunedin women. NZ Med J 1997; 110: 275-7.
  • Graafmans WC, Lips P, Ooms ME, van LJ, Pols HA, Uitterlinden AG. The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype [In Process Citation]. J Bone Miner Res 1997; 12: 1241-5.
  • O'Dowd KJ, Clemens TL, Kelsey JL, Lindsay R. Exogenous calciferol (vitamin D) and vitamin D endocrine status among elderly nursing home residents in the New York City area [see comments]. J Am Geriatr Soc 1993; 41: 414-21.
  • Dawson-Hughes B, Harris SS, Krall EA, Dallal GE, Falconer G, Green CL. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr 1995; 61: 1140- 5.
  • Sebert JL, Garabedian M, Chauvenet M, Maamer M, Agbomson F, Brazier M. Evaluation of a new solid formulation of calcium and vitamin D in institutionalize d elderly subjects. A randomized comparative trial versus separate administratio n of both constituents. Rev Rheum 1995; 62: 288-94.
  • Van Der Klis FR, Jonxis JH, Van DJ, Sikkens P, Saleh AE, Muskiet FA. Changes in vitamin-D metabolites and parathyroi d hormone in plasma following cholecalcifero l administratio n to pre- and postmenopausal women in the Netherlands in early spring and to postmenopausal women in Curacao. Br J Nutr 1996; 75: 637-46.
  • Lips P, Wiersinga A, van GF et al. The effect of vitamin D supplementation on vitamin D status and parathyroi d function in elderly subjects. J Clin Endocrinol Metab 1988; 67: 644-50.
  • Chapuy MC, Chapuy P, Thomas JL, Hazard MC, Meunier PJ. Biochemical effects of calcium and vitamin D supplementatio n in elderly, institutionalized , vitamin D-deficient patients. Rev Rheum 1996; 63: 135-40.
  • Freaney R, McBrinn Y, McKenna MJ. Secondary hyperparathyroidis m in elderly people: combined effect of renal insufficiency and vitamin D deficiency. Am J Clin Nutr 1993; 58: 187-91.
  • McKenna MJ, Freaney R, Meade A, Muldowney FP. Prevention of hypovitaminosis D in the elderly. Calcif Tissue Int 1985; 37: 112-16.
  • Prestwood KM, Thompson DL, Kenny AM, Seibel MJ, Pilbeam CC, Raisz LG. Low dose estrogen and calcium have an additive effect on bone resorption in older women. J Clin Endocrinol Metab 1999; 84: 179-83.
  • Krieg MA, Jacquet AF, Bremgartner M, Cuttelod S, Thiebaud D, Burckhardt P. Effect of supplementation with vitamin D3 and calcium on quantitativ e ultrasound of bone in elderly institutionalized women: a longitudinal study. Osteoporosis Int 1999; 9: 483-8.
  • Kyriakidou-Himonas M, Aloia JF, Yeh JK. Vitamin D supplementation in postmenopausal black women [In Process Citation]. J Clin Endocrinol Metab 1999; 84: 3988-90.
  • Francis RM, Boyle IT, Moniz C et al. A comparison of the effects of alfacalcido l treatment and vitamin D2 supplementatio n on calcium absorption in elderly women with vertebral fractures. Osteoporosis Int 1996; 6: 284-90.
  • Sorva A, Risteli J, Risteli L, Valimaki M, Tilvis R. Effects of vitamin D and calcium on markers of bone metabolism in geriatric patients with low serum 25-hydroxyvitami n D levels. Calcif Tissue Int 1991; 49(Suppl.) : S88-9.
  • Honkanen R, Alhava E, Parviainen M, Talasniemi S, Monkkonen R. The necessity and safety of calcium and vitamin D in the elderly. J Am Geriatr Soc 1990; 38: 862- 6.
  • MacLennan WJ, Hamilton JC. Vitamin D supplement s and 25-hydrox y vitamin D concentration s in the elderly. Br Med J 1977; 2: 859-61.
  • Nordin BE, Baker MR, Horsman A, Peacock M. A prospective trial of the effect of vitamin D supplementation on metacarpal bone loss in elderly women. Am J Clin Nutr 1985; 42: 470- 4.
  • Papapoulos SE, Clemens TL, Fraher LJ, Gleed J, O'Riordan JL. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol. Lancet 1980; 2: 612-15.
  • Tjellesen L, Christiansen C, Rodbro P, Hummer L. Different metabolism of vitamin D2 and vitamin D3 in epileptic patients on carbamazepine. Acta Neurol Scand 1985; 71: 385-9.
  • Malabanan A, Veronikis IE, Holick MF. Rede. ning vitamin D insufficiency [Letter]. Lancet 1998; 351: 805- 6.
  • Arthur RS, Piraino B, Candib D, Cooperstein L, Chen T, West CPJ. Effect of low-dose calcitrio l and calcium therapy on bone histomorphometry and urinary calcium excretion in osteopenic women. Miner Electrolyte Metab 1990; 16: 385-90.
  • Adams JS, Kantorovich V, Wu C, Javanbakh t M, Hollis BW. Resolution of vitamin D insufficiency in osteopeni c patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab 1999; 84: 2729-30.
  • Mason RS, Lissner D, Grunstein HS, Posen S. A simpli. ed assay for dihydroxylate d vitamin D metabolites in human serum: application to hyper- and hypovitaminosis D. Clin Chem 1980; 26: 444-50.
  • Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF. Vitamin D and its major metabolites : serum levels after graded oral dosing in healthy men. Osteoporosis Int 1998; 8: 222-30.
  • Gertner JM, Domenech M. 25-hydroxyvitami n D levels in patients treated with high-dosage ergo- and cholecalciferol. Clin Pathol 1977; 30: 144-50.
  • Hathcock JN. Tolerable upper intake level of vitamin D. Am J Clin Nutr (in press).
  • Munro I. Tolerable upper intake level of vitamin D. Am J Clin Nutr (in press).
  • Jacobus CH, Holick MF, Shao Q et al. Hypervitaminosis D associated with drinking milk [see comments]. N Engl J Med 1992; 326: 1173-7.
  • Blank S, Scanlon KS, Sinks TH, Lett S, Falk H. An outbreak of hypervitaminosis D associated with the overforti fication of milk from a home-deliver y dairy. Am J Public Health 1995; 85: 656-9.
  • Vieth R, Bayley TA, Wal. sh PG, Rosen IB, Pollard A. Relevance of vitamin D metabolite concentration s in supporting the diagnosis of primary hyperparathyroidism. Surgery 1991; 110: 1043-6 (discussion 1046-7).
  • Brouwer DA, van Beek J, Ferwerda H et al. Rat adipose tissue rapidly accumulate s and slowly releases an orally-administere d high vitamin D dose. Br J Nutr 1998; 79: 527-32.
  • Pettifor JM, Bikle DD, Cavaleros M, Zachen D, Kamdar MC, Ross FP. Serum levels of free 1,25-dihydroxyvitami n D in vitamin D toxicity. Ann Intern Med 1995; 122: 511-13.
  • Montgomery JL, Parrish FC Jr., Beitz DC, Horst RL, Huff-Lonergan EJ, Trenkle AH. The use of vitamin D3 to improve beef tenderness. J Anim Sci 2000; 78: 2615-21.
  • Vieth R. Simple method for determining specific binding capacity of vitamin D-binding protein and its use to calculate the concentration of 'free' 1,25-dihydroxyvitami n D. Clin Chem 1994; 40: 435-41.
  • Narang NK, Gupta RC, Jain MK, Aaronson K. Role of vitamin D in pulmonary tuberculosis. J Assoc Phys India 1984; 32: 185-6.
  • Vieth R, Carter G. Difficulties with vitamin D nutrition research: objective targets of adequacy, and assays for 25-hydroxyvitami n D. Eur J Clin Nutr 2001; 55: 221-2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.